BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34582980)

  • 1. Update on SARS-CoV-2 seroprevalence: regional and worldwide.
    Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
    Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
    EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
    Liang Y; Sun Q; Liu Q; Pang Y; Tang S
    Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis.
    Naeimi R; Sepidarkish M; Mollalo A; Parsa H; Mahjour S; Safarpour F; Almukhtar M; Mechaal A; Chemaitelly H; Sartip B; Marhoommirzabak E; Ardekani A; Hotez PJ; Gasser RB; Rostami A
    EClinicalMedicine; 2023 Feb; 56():101786. PubMed ID: 36590788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.
    Vaughan A; Duffell E; Freidl GS; Lemos DS; Nardone A; Valenciano M; Subissi L; Bergeri I; K Broberg E; Penttinen P; Pebody R; Keramarou M
    BMJ Open; 2023 Nov; 13(11):e064240. PubMed ID: 37931969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
    He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA
    J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.
    Azami M; Moradi Y; Moradkhani A; Aghaei A
    Eur J Med Res; 2022 Jun; 27(1):81. PubMed ID: 35655237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.
    Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC
    Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    COVID-19 Forecasting Team
    Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.
    Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV
    Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence estimates for toxocariasis in people worldwide: A systematic review and meta-analysis.
    Rostami A; Riahi SM; Holland CV; Taghipour A; Khalili-Fomeshi M; Fakhri Y; Omrani VF; Hotez PJ; Gasser RB
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007809. PubMed ID: 31856156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.
    Chen X; Chen Z; Azman AS; Deng X; Sun R; Zhao Z; Zheng N; Chen X; Lu W; Zhuang T; Yang J; Viboud C; Ajelli M; Leung DT; Yu H
    Lancet Glob Health; 2021 May; 9(5):e598-e609. PubMed ID: 33705690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis.
    Figueiredo GM; Tengan FM; Campos SR; Luna EJ
    Clinics (Sao Paulo); 2023; 78():100233. PubMed ID: 37348256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis.
    Abbasi F; Almukhtar M; Fazlollahpour-Naghibi A; Alizadeh F; Behzad Moghadam K; Jafari Tadi M; Ghadimi S; Bagheri K; Babaei H; Bijani MH; Rouholamin S; Razavi M; Rezaeinejad M; Chemaitelly H; Sepidarkish M; Farid-Mojtahedi M; Rostami A
    EClinicalMedicine; 2023 Dec; 66():102327. PubMed ID: 38045801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
    Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö
    Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.